In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kwality Pharmaceuticals has informed that it enclosed disclosure of related party transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/ CIR/P/2021/662 dated November 22, 2021, for the half year ended September 30, 2022. The aforesaid details of related party transaction will also be available on the Company's website at www.kwalitypharma.com
The above information is a part of company’s filings submitted to BSE.
